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. To address the problem of long waiting times, our team designed an interactive eHealth program (eADVICE: electronic Advice and Diagnosis Via the Internet following Computerised Evaluation) 2 which enables the exchange of information between the child, parents and specialists using a virtual character ("avatar") to provide individualized treatment advice to families, supervised by their general practitioners, while they awaited their specialist appointment. The aim of our pilot study was to assess the acceptance and usage of the eADVICE program, children's adherence to the treatment advised and the clinical outcomes after 6 months of access. Methods: Children aged 5 to 18 years, referred to the continence service at the Children's Hospital at Westmead in 2015 with daytime urinary incontinence or enuresis, were offered access to eADVICE while they awaited their clinic appointment. Patients had access for 6 months, with opportunity to revisit the program every 2 weeks for further assessment and advice if they wished during that time. Outcomes of interest were program usage, change in frequency of wetting, adherence to treatment advice, adverse events and acceptance of the program by families.
Results: 55% (79/143) of eligible families enrolled in the study. 62% had monosymptomatic enuresis, 36% had nonmonosymptomatic enuresis (day and night wetting) and 2% had isolated daytime urinary incontinence. 76% (60/79) accessed the program, with an average of 3 accesses per family. 49% had improvement in enuresis and 73% had improvement in daytime incontinence, with 38% becoming completely dry after 6 months' access. Adherence to treatment advice varied, with 100% reporting adherence to reducing caffeine consumption, 97% to advice about increasing or reducing fluid intake, 94% to using a bowel program, 72% to a timed voiding program, 62% to alarm training and 50% to seeing a doctor regarding medication when advised by the program some or all the time. Most (85%) respondents had tried at least one treatments. 90% experienced no side effects, and 70% of parents and 61% of children were happy with the treatment.
Conclusions: eADVICE was used by many families while awaiting a specialist appointment, and appeared to be well received by children and families. It often resulted in improvement in continence symptoms before seeing the specialist, with some no longer requiring an appointment. eADVICE demonstrates an innovative model of outpatient care that may be generalizable to other subacute health conditions. Background: Daytime urinary incontinence (DUI) occurs in 19% of school-aged children with 2% wetting at least twice per week (1). It can have a profound effect on the quality of life, selfesteem, teasing and social problems, which improves with successful treatment (2). Timed voiding (voiding to a fixed schedule) is effective for treating DUI in adults (3). One study demonstrated that an alarm watch may be effective for treating DUI in children (4). We wish to test whether a standard watch is as effective as an alarm watch for treating DUI in children.
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Methods: We conducted a randomized controlled trial for children aged 5 to 13 years with daytime urinary incontinence referred to the continence service at the Children's Hospital at Westmead. Children were randomized to either a personalised alarm watch (with the alarm on the watch set to approximately two hourly intervals by the trial coordinator at times defined by the parents to fit in with the child's daily routine and then "locked" to prevent tampering) or an identical watch (with normal time and date set by the trial coordinator) to help them with timed voiding. Participants were stratified by age, gender, severity of DUI and other treatments received. The primary outcome was the proportion of children who was dry during the day at 3 months. Secondary outcomes include change in frequency of incontinence, completeness of bladder emptying, satisfaction with treatment and quality of life.
Results: 241/375 (64%) eligible patients enrolled in the study (121 alarm watch and 119 control). Participants were aged 5 to 13 years, and 37% (90/241) were boys. At baseline, the frequency and severity of daytime incontinence were similar between groups, but 39% versus 31% (p=0.01) in the alarm watch and control groups respectively had a post void residual volume of 10mls or more at baseline. After 3 months of treatment, 15% versus 12% (p=0.5) in the alarm watch and controls group respectively became dry, with 64% versus 42% (p<0.001) having a greater than 50% reduction in their frequency of wetting. 66% vs 55% (p=0.3) who had incomplete bladder emptying at baseline in the alarm watch and controls group respectively had resolution of their incomplete emptying. However, 14% of
